Kefrenex (Quetiapine)

Quetiapine works by blocking several neurotransmitter receptors, especially serotonin 5‑HT2A and dopamine D2 receptors. This antagonism reduces excessive dopaminergic and serotonergic activity, helping to control psychotic symptoms, stabilize mood, and improve depressive symptoms in the conditions for which it is prescribed.

The appropriate dose of Kefrenex is individualized and determined by a qualified prescriber based on the specific condition, patient age, response, and tolerability. Dosage adjustments are made according to clinical judgment and therapeutic goals.

Safety data for quetiapine in pregnancy and lactation are limited. The medication should only be used if the potential benefits outweigh the risks, and this decision must be made by a healthcare professional in consultation with the patient.

To order Kefrenex, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Kefrenex (quetiapine) is an atypical antipsychotic with a broader receptor profile than many typical agents, offering both antipsychotic and mood‑stabilising effects. Compared with drugs such as risperidone, quetiapine often has a lower risk of extrapyramidal symptoms but may cause more sedation and metabolic changes, influencing the choice based on patient needs.

Kefrenex tablets should be stored at ambient temperature, preferably below 25 °C, in the original blister or container to protect them from moisture and light. Keep the medication out of reach of children and do not use after the expiry date.

Kefrenex is taken orally, usually as a tablet swallowed whole with water. It may be taken with or without food, but patients should follow the prescriber’s instructions regarding timing and any dose‑adjustment schedule.

Serious adverse reactions to Kefrenex include neuroleptic malignant syndrome, tardive dyskinesia, severe hypotension, and rare blood dyscrasias such as agranulocytosis. Patients should be monitored for signs of these conditions and seek immediate medical attention if they occur.

Kefrenex should not be used by individuals with known hypersensitivity to quetiapine or any of its excipients. Caution is also advised for patients with uncontrolled cardiovascular disease, severe hepatic impairment, or a history of neuroleptic malignant syndrome.